Global Estradiol Transdermal System Market Size, Status and Forecast 2020-2026

May 2020 | 95 pages | ID: GF1EB46D8447EN
QYResearch

Abstracts

This report focuses on the global Estradiol Transdermal System status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Estradiol Transdermal System development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Novartis
• Allergan
• Bayer
• Noven Therapeutics
• Mylan
• Vertical Pharmaceuticals
• Perrigo Pharma International
• ...

Market segment by Type, the product can be split into

• 0.025 mg per day
• 0.0375 mg per day
• 0.05 mg per day
• 0.075 mg per day
• 0.1 mg per day

Market segment by Application, split into

• Hot flashes
• Prevention of postmenopausal osteoporosis
• Treatment of hypoestrogenism
• Moderate-to-severe vasomotor symptoms
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Estradiol Transdermal System status, future forecast, growth opportunity, key market and key players.
• To present the Estradiol Transdermal System development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Estradiol Transdermal System are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Estradiol Transdermal System Revenue
1.4 Market Analysis by Type
  1.4.1 Global Estradiol Transdermal System Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 0.025 mg per day
  1.4.3 0.0375 mg per day
  1.4.4 0.05 mg per day
  1.4.5 0.075 mg per day
  1.4.6 0.1 mg per day
1.5 Market by Application
  1.5.1 Global Estradiol Transdermal System Market Share by Application: 2020 VS 2026
  1.5.2 Hot flashes
  1.5.3 Prevention of postmenopausal osteoporosis
  1.5.4 Treatment of hypoestrogenism
  1.5.5 Moderate-to-severe vasomotor symptoms
  1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Estradiol Transdermal System Market Perspective (2015-2026)
2.2 Estradiol Transdermal System Growth Trends by Regions
  2.2.1 Estradiol Transdermal System Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Estradiol Transdermal System Historic Market Share by Regions (2015-2020)
  2.2.3 Estradiol Transdermal System Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Estradiol Transdermal System Market Growth Strategy
  2.3.6 Primary Interviews with Key Estradiol Transdermal System Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Estradiol Transdermal System Players by Market Size
  3.1.1 Global Top Estradiol Transdermal System Players by Revenue (2015-2020)
  3.1.2 Global Estradiol Transdermal System Revenue Market Share by Players (2015-2020)
  3.1.3 Global Estradiol Transdermal System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Estradiol Transdermal System Market Concentration Ratio
  3.2.1 Global Estradiol Transdermal System Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Estradiol Transdermal System Revenue in 2019
3.3 Estradiol Transdermal System Key Players Head office and Area Served
3.4 Key Players Estradiol Transdermal System Product Solution and Service
3.5 Date of Enter into Estradiol Transdermal System Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Estradiol Transdermal System Historic Market Size by Type (2015-2020)
4.2 Global Estradiol Transdermal System Forecasted Market Size by Type (2021-2026)

5 ESTRADIOL TRANSDERMAL SYSTEM BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Estradiol Transdermal System Market Size by Application (2015-2020)
5.2 Global Estradiol Transdermal System Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Estradiol Transdermal System Market Size (2015-2020)
6.2 Estradiol Transdermal System Key Players in North America (2019-2020)
6.3 North America Estradiol Transdermal System Market Size by Type (2015-2020)
6.4 North America Estradiol Transdermal System Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Estradiol Transdermal System Market Size (2015-2020)
7.2 Estradiol Transdermal System Key Players in Europe (2019-2020)
7.3 Europe Estradiol Transdermal System Market Size by Type (2015-2020)
7.4 Europe Estradiol Transdermal System Market Size by Application (2015-2020)

8 CHINA

8.1 China Estradiol Transdermal System Market Size (2015-2020)
8.2 Estradiol Transdermal System Key Players in China (2019-2020)
8.3 China Estradiol Transdermal System Market Size by Type (2015-2020)
8.4 China Estradiol Transdermal System Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Estradiol Transdermal System Market Size (2015-2020)
9.2 Estradiol Transdermal System Key Players in Japan (2019-2020)
9.3 Japan Estradiol Transdermal System Market Size by Type (2015-2020)
9.4 Japan Estradiol Transdermal System Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Estradiol Transdermal System Market Size (2015-2020)
10.2 Estradiol Transdermal System Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Estradiol Transdermal System Market Size by Type (2015-2020)
10.4 Southeast Asia Estradiol Transdermal System Market Size by Application (2015-2020)

11 INDIA

11.1 India Estradiol Transdermal System Market Size (2015-2020)
11.2 Estradiol Transdermal System Key Players in India (2019-2020)
11.3 India Estradiol Transdermal System Market Size by Type (2015-2020)
11.4 India Estradiol Transdermal System Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Estradiol Transdermal System Market Size (2015-2020)
12.2 Estradiol Transdermal System Key Players in Central & South America (2019-2020)
12.3 Central & South America Estradiol Transdermal System Market Size by Type (2015-2020)
12.4 Central & South America Estradiol Transdermal System Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Novartis
  13.1.1 Novartis Company Details
  13.1.2 Novartis Business Overview and Its Total Revenue
  13.1.3 Novartis Estradiol Transdermal System Introduction
  13.1.4 Novartis Revenue in Estradiol Transdermal System Business (2015-2020))
  13.1.5 Novartis Recent Development
13.2 Allergan
  13.2.1 Allergan Company Details
  13.2.2 Allergan Business Overview and Its Total Revenue
  13.2.3 Allergan Estradiol Transdermal System Introduction
  13.2.4 Allergan Revenue in Estradiol Transdermal System Business (2015-2020)
  13.2.5 Allergan Recent Development
13.3 Bayer
  13.3.1 Bayer Company Details
  13.3.2 Bayer Business Overview and Its Total Revenue
  13.3.3 Bayer Estradiol Transdermal System Introduction
  13.3.4 Bayer Revenue in Estradiol Transdermal System Business (2015-2020)
  13.3.5 Bayer Recent Development
13.4 Noven Therapeutics
  13.4.1 Noven Therapeutics Company Details
  13.4.2 Noven Therapeutics Business Overview and Its Total Revenue
  13.4.3 Noven Therapeutics Estradiol Transdermal System Introduction
  13.4.4 Noven Therapeutics Revenue in Estradiol Transdermal System Business (2015-2020)
  13.4.5 Noven Therapeutics Recent Development
13.5 Mylan
  13.5.1 Mylan Company Details
  13.5.2 Mylan Business Overview and Its Total Revenue
  13.5.3 Mylan Estradiol Transdermal System Introduction
  13.5.4 Mylan Revenue in Estradiol Transdermal System Business (2015-2020)
  13.5.5 Mylan Recent Development
13.6 Vertical Pharmaceuticals
  13.6.1 Vertical Pharmaceuticals Company Details
  13.6.2 Vertical Pharmaceuticals Business Overview and Its Total Revenue
  13.6.3 Vertical Pharmaceuticals Estradiol Transdermal System Introduction
  13.6.4 Vertical Pharmaceuticals Revenue in Estradiol Transdermal System Business (2015-2020)
  13.6.5 Vertical Pharmaceuticals Recent Development
13.7 Perrigo Pharma International
  13.7.1 Perrigo Pharma International Company Details
  13.7.2 Perrigo Pharma International Business Overview and Its Total Revenue
  13.7.3 Perrigo Pharma International Estradiol Transdermal System Introduction
  13.7.4 Perrigo Pharma International Revenue in Estradiol Transdermal System Business (2015-2020)
  13.7.5 Perrigo Pharma International Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Estradiol Transdermal System Key Market Segments
Table 2. Key Players Covered: Ranking by Estradiol Transdermal System Revenue
Table 3. Ranking of Global Top Estradiol Transdermal System Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Estradiol Transdermal System Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of 0.025 mg per day
Table 6. Key Players of 0.0375 mg per day
Table 7. Key Players of 0.05 mg per day
Table 8. Key Players of 0.075 mg per day
Table 9. Key Players of 0.1 mg per day
Table 10. Global Estradiol Transdermal System Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Estradiol Transdermal System Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Estradiol Transdermal System Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Estradiol Transdermal System Market Share by Regions (2015-2020)
Table 14. Global Estradiol Transdermal System Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Estradiol Transdermal System Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Estradiol Transdermal System Market Growth Strategy
Table 20. Main Points Interviewed from Key Estradiol Transdermal System Players
Table 21. Global Estradiol Transdermal System Revenue by Players (2015-2020) (Million US$)
Table 22. Global Estradiol Transdermal System Market Share by Players (2015-2020)
Table 23. Global Top Estradiol Transdermal System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Estradiol Transdermal System as of 2019)
Table 24. Global Estradiol Transdermal System by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Estradiol Transdermal System Product Solution and Service
Table 27. Date of Enter into Estradiol Transdermal System Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Estradiol Transdermal System Market Size by Type (2015-2020) (Million US$)
Table 30. Global Estradiol Transdermal System Market Size Share by Type (2015-2020)
Table 31. Global Estradiol Transdermal System Revenue Market Share by Type (2021-2026)
Table 32. Global Estradiol Transdermal System Market Size Share by Application (2015-2020)
Table 33. Global Estradiol Transdermal System Market Size by Application (2015-2020) (Million US$)
Table 34. Global Estradiol Transdermal System Market Size Share by Application (2021-2026)
Table 35. North America Key Players Estradiol Transdermal System Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Estradiol Transdermal System Market Share (2019-2020)
Table 37. North America Estradiol Transdermal System Market Size by Type (2015-2020) (Million US$)
Table 38. North America Estradiol Transdermal System Market Share by Type (2015-2020)
Table 39. North America Estradiol Transdermal System Market Size by Application (2015-2020) (Million US$)
Table 40. North America Estradiol Transdermal System Market Share by Application (2015-2020)
Table 41. Europe Key Players Estradiol Transdermal System Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Estradiol Transdermal System Market Share (2019-2020)
Table 43. Europe Estradiol Transdermal System Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Estradiol Transdermal System Market Share by Type (2015-2020)
Table 45. Europe Estradiol Transdermal System Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Estradiol Transdermal System Market Share by Application (2015-2020)
Table 47. China Key Players Estradiol Transdermal System Revenue (2019-2020) (Million US$)
Table 48. China Key Players Estradiol Transdermal System Market Share (2019-2020)
Table 49. China Estradiol Transdermal System Market Size by Type (2015-2020) (Million US$)
Table 50. China Estradiol Transdermal System Market Share by Type (2015-2020)
Table 51. China Estradiol Transdermal System Market Size by Application (2015-2020) (Million US$)
Table 52. China Estradiol Transdermal System Market Share by Application (2015-2020)
Table 53. Japan Key Players Estradiol Transdermal System Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Estradiol Transdermal System Market Share (2019-2020)
Table 55. Japan Estradiol Transdermal System Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Estradiol Transdermal System Market Share by Type (2015-2020)
Table 57. Japan Estradiol Transdermal System Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Estradiol Transdermal System Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Estradiol Transdermal System Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Estradiol Transdermal System Market Share (2019-2020)
Table 61. Southeast Asia Estradiol Transdermal System Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Estradiol Transdermal System Market Share by Type (2015-2020)
Table 63. Southeast Asia Estradiol Transdermal System Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Estradiol Transdermal System Market Share by Application (2015-2020)
Table 65. India Key Players Estradiol Transdermal System Revenue (2019-2020) (Million US$)
Table 66. India Key Players Estradiol Transdermal System Market Share (2019-2020)
Table 67. India Estradiol Transdermal System Market Size by Type (2015-2020) (Million US$)
Table 68. India Estradiol Transdermal System Market Share by Type (2015-2020)
Table 69. India Estradiol Transdermal System Market Size by Application (2015-2020) (Million US$)
Table 70. India Estradiol Transdermal System Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Estradiol Transdermal System Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Estradiol Transdermal System Market Share (2019-2020)
Table 73. Central & South America Estradiol Transdermal System Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Estradiol Transdermal System Market Share by Type (2015-2020)
Table 75. Central & South America Estradiol Transdermal System Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Estradiol Transdermal System Market Share by Application (2015-2020)
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Product
Table 80. Novartis Revenue in Estradiol Transdermal System Business (2015-2020) (Million US$)
Table 81. Novartis Recent Development
Table 82. Allergan Company Details
Table 83. Allergan Business Overview
Table 84. Allergan Product
Table 85. Allergan Revenue in Estradiol Transdermal System Business (2015-2020) (Million US$)
Table 86. Allergan Recent Development
Table 87. Bayer Company Details
Table 88. Bayer Business Overview
Table 89. Bayer Product
Table 90. Bayer Revenue in Estradiol Transdermal System Business (2015-2020) (Million US$)
Table 91. Bayer Recent Development
Table 92. Noven Therapeutics Company Details
Table 93. Noven Therapeutics Business Overview
Table 94. Noven Therapeutics Product
Table 95. Noven Therapeutics Revenue in Estradiol Transdermal System Business (2015-2020) (Million US$)
Table 96. Noven Therapeutics Recent Development
Table 97. Mylan Company Details
Table 98. Mylan Business Overview
Table 99. Mylan Product
Table 100. Mylan Revenue in Estradiol Transdermal System Business (2015-2020) (Million US$)
Table 101. Mylan Recent Development
Table 102. Vertical Pharmaceuticals Company Details
Table 103. Vertical Pharmaceuticals Business Overview
Table 104. Vertical Pharmaceuticals Product
Table 105. Vertical Pharmaceuticals Revenue in Estradiol Transdermal System Business (2015-2020) (Million US$)
Table 106. Vertical Pharmaceuticals Recent Development
Table 107. Perrigo Pharma International Company Details
Table 108. Perrigo Pharma International Business Overview
Table 109. Perrigo Pharma International Product
Table 110. Perrigo Pharma International Revenue in Estradiol Transdermal System Business (2015-2020) (Million US$)
Table 111. Perrigo Pharma International Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Estradiol Transdermal System Market Share by Type: 2020 VS 2026
Figure 2. 0.025 mg per day Features
Figure 3. 0.0375 mg per day Features
Figure 4. 0.05 mg per day Features
Figure 5. 0.075 mg per day Features
Figure 6. 0.1 mg per day Features
Figure 7. Global Estradiol Transdermal System Market Share by Application: 2020 VS 2026
Figure 8. Hot flashes Case Studies
Figure 9. Prevention of postmenopausal osteoporosis Case Studies
Figure 10. Treatment of hypoestrogenism Case Studies
Figure 11. Moderate-to-severe vasomotor symptoms Case Studies
Figure 12. Others Case Studies
Figure 13. Estradiol Transdermal System Report Years Considered
Figure 14. Global Estradiol Transdermal System Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Estradiol Transdermal System Market Share by Regions: 2020 VS 2026
Figure 16. Global Estradiol Transdermal System Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Estradiol Transdermal System Market Share by Players in 2019
Figure 19. Global Top Estradiol Transdermal System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Estradiol Transdermal System as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Estradiol Transdermal System Revenue in 2019
Figure 21. North America Estradiol Transdermal System Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Estradiol Transdermal System Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Estradiol Transdermal System Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Estradiol Transdermal System Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Estradiol Transdermal System Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Estradiol Transdermal System Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Estradiol Transdermal System Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Novartis Revenue Growth Rate in Estradiol Transdermal System Business (2015-2020)
Figure 30. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Allergan Revenue Growth Rate in Estradiol Transdermal System Business (2015-2020)
Figure 32. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Bayer Revenue Growth Rate in Estradiol Transdermal System Business (2015-2020)
Figure 34. Noven Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Noven Therapeutics Revenue Growth Rate in Estradiol Transdermal System Business (2015-2020)
Figure 36. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Mylan Revenue Growth Rate in Estradiol Transdermal System Business (2015-2020)
Figure 38. Vertical Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Vertical Pharmaceuticals Revenue Growth Rate in Estradiol Transdermal System Business (2015-2020)
Figure 40. Perrigo Pharma International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Perrigo Pharma International Revenue Growth Rate in Estradiol Transdermal System Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed